Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Timmermans notes that the patent for BPC-157 expired long ago, which means that no company presently has a clear profit motive to spend millions to fund human studies
TB 500 is a synthetic version designed to mimic its healing effects while being more stable and effective for therapeutic use
10.1007/s00210-025-04191-y 37 Hafez HafezM.El-KazazS
Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)
It comes in a multidose 30 mL vial (plastic, fliptop) from which you can withdraw multiple aliquots
